Dr. Christopher Moertel, MD

• Pediatric Hematology & Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Baylor College Of Med|mayo Grad School Med/mayo Fndn

  Residency Hospital

• University Of Minnesota / Saint Paul Campus

  Medical School, 1987

• PTENandNF1inactivation in Schwann cells produces a severe phenotype in the peripheral nervous system that promotes the development and malignant progression of peripheral nerve sheath tumors, 2012-06-14

• Predictive Value and Inter-Rater Reliability of Radiographic Factors in Neurofibromatosis Patients with Dystrophic Scoliosis, 2018-05-02

• Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity, 2014-01-20

• Sustained Remission of Severe Multicentric Castleman Disease Following Multiagent Chemotherapy and Tocilizumab Maintenance, 2013-09-09

• Incidence of second malignancies in individuals diagnosed with malignant peripheral nerve sheath tumors, 2020-04-01

• Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and genetic pathways driving tumorigenesis, 2013-05-19

• Perinatal folate levels do not influence tumor latency or multiplicity in a model of NF1 associated plexiform-like neurofibromas, 2023-10-17

• Sex differences in methylation profiles are apparent in medulloblastoma, particularly among SHH tumors, 2023-03-24

• Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1, 2018-10-02

• Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1, 2018-06-18

• Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo, 2021-02-10

• Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma, 2019-01-24

• CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy, 2014-12-16

• The Role of Socioeconomic Status and Race/Ethnicity in Malignant Peripheral Nerve Sheath Tumor Survival: A Surveillance, Epidemiology and End Results Based Analysis, 2022-09-02

• Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity, 2020-09-29